Terns Pharmaceuticals
TERN
TERN
103 hedge funds and large institutions have $424M invested in Terns Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 33 increasing their positions, 22 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
103
Holders Change
+10
Holders Change %
+10.75%
% of All Funds
1.51%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
26
Increased
33
Reduced
22
Closed
15
Calls
$1.58M
Puts
$249K
Net Calls
+$1.33M
Net Calls Change
-$749K
Top Buyers
1 |
1
Morgan Stanley
New York
|
$22.4M |
2 |
2
Janus Henderson Group
London,
United Kingdom
|
$9.25M |
3 |
VA
3
VR Adviser
New York
|
$29.2M |
4 |
![]()
4
Adage Capital Partners
Boston,
Massachusetts
|
$6.81M |
5 |
GPP
5
Great Point Partners
Greenwich,
Connecticut
|
$8.5M |